TrademarkOpen
Search / United States / 97497985

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

E

Registered
Used for: Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression…
Show more

Class 5: Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; short interfering RNA (siRNA) medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradat…
Class 9: Downloadable and recorded computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; downloadable computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; downloadable databases in the field of pharmaceuticals, medicines and drug discovery; electronic databa…
Class 40: Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid
Class 42: Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABD…

Class 5 – Pharmaceuticals & supplementsClass 9 – Software, electronics & scientificClass 40 – Materials treatmentClass 42 – Technology & SaaS

Status timeline

  1. 14 Jul 2022
    Application filed
    New Application Entered
  2. 25 Apr 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 27 Apr 2023
    Office action issued
    Non-Final Action Written
  4. 26 Jun 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 7 Jan 2024
    Approved for publication
    Approved For Pub - Principal Register
  6. 13 Feb 2024
    Published for opposition
    Published For Opposition
  7. 9 Apr 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 25 Feb 2025
    Registered on the Principal Register
    Registered-Principal Register
  9. 10 Jun 2026
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
All 27 events
2026-06-10Automatic Update Of Assignment Of Ownership
2025-02-25Registered-Principal Register
2025-02-25Notice Of Registration Confirmation Emailed
2024-10-09Notice Of Allowance Cancelled
2024-10-091(B) Basis Deleted; Proceed To Registration
2024-09-26Teas Delete 1(B) Basis Received
2024-04-09Noa Mailed - Sou Required From Applicant
2024-02-13Published For Opposition
2024-02-13Official Gazette Publication Confirmation E-Mailed
2024-01-24Notification Of Notice Of Publication E-Mailed
2024-01-07Approved For Pub - Principal Register
2024-01-05Examiners Amendment -Written
2024-01-05Examiners Amendment E-Mailed
2024-01-05Notification Of Examiners Amendment E-Mailed
2024-01-05Examiner's Amendment Entered
2023-11-30Assigned To Lie
2023-11-30Correspondence Received In Law Office
2023-11-30Teas/Email Correspondence Entered
2023-06-26Teas Response To Office Action Received
2023-04-27Non-Final Action Written
2023-04-27Non-Final Action E-Mailed
2023-04-27Notification Of Non-Final Action E-Mailed
2023-04-25Assigned To Examiner
2023-04-19Teas Voluntary Amendment Received
2022-07-30Notice Of Design Search Code E-Mailed
2022-07-29New Application Office Supplied Data Entered
2022-07-14New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; short interfering RNA (siRNA) medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradat…

Class 9 Software, electronics & scientific

Downloadable and recorded computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; downloadable computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; downloadable databases in the field of pharmaceuticals, medicines and drug discovery; electronic databa…

Class 40 Materials treatment

Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid

Class 42 Technology & SaaS

Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABD…

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 11 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.